Tom Monath, MD

Chief Medical Officer

Dr. Tom Monath is an internationally recognized virologist and vaccinologist with over 50 years’ experience in research on viral and bacterial diseases, 25 of which have been in the vaccines industry. His expertise spans discovery research and all functional areas of product development. He has worked in leadership positions in US government agencies and in the biotechnology sector. He had primary responsibility for bringing multiple innovative vaccines into clinical development, including Ebola Zaire, cell based smallpox, dengue, Japanese encephalitis, West Nile, cytomegalovirus, influenza, live and inactivated yellow fever, Helicobacter pylori, Clostridium difficile, four of which are now licensed and commercialized.

Tom received his AB degree from Harvard College and his MD from Harvard Medical School and is board certified in internal medicine. He has received many prestigious awards, including the Nathanial A. Young Award (1984), the Richard M. Taylor Award (1996), the Walter Reed Medal (2002) and the James H. Steele Gold-Headed Cane Award (2015). He has served on numerous government and international committees on infectious diseases, biosecurity, WHO expert committees and the National Vaccines Advisory Committee (USA), and is Past-President of the American Society of Tropical Medicine and Hygiene and an elected Fellow of the Society. He has been a leader in and founding member of the One Health Initiative and is an expert in arthropod-borne viruses. He has published over 425 scientific papers and 6 books on virology and vaccine development and has 35 patents.

More team members

Andrew Fradkin, JD
General Counsel
Walter Greenblatt, MBA
Chief Financial Officer
Mike McGinnis, MS, MBA
Head of Government Relations
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Chairwoman of the Board
Fred Hayden, MD
Joan Fusco, PhD
Chief Development Officer
Sean Whelan, PhD
Allen Duplantier, PhD
Principal investigator
Daniel Graifman, MBA